362 related articles for article (PubMed ID: 8363279)
1. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
Fitzgerald D; Pastan I
Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
[TBL] [Abstract][Full Text] [Related]
2. Redirecting Pseudomonas exotoxin.
FitzGerald D; Pastan I
Semin Cell Biol; 1991 Feb; 2(1):31-7. PubMed ID: 1954341
[TBL] [Abstract][Full Text] [Related]
3. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
Weldon JE; Pastan I
FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
[TBL] [Abstract][Full Text] [Related]
4. Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins.
Pirzer T; Becher KS; Rieker M; Meckel T; Mootz HD; Kolmar H
ACS Chem Biol; 2018 Aug; 13(8):2058-2066. PubMed ID: 29920062
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Resistance to Immunotoxins Containing
Dieffenbach M; Pastan I
Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32630017
[TBL] [Abstract][Full Text] [Related]
6. Role of caspases in immunotoxin-induced apoptosis of cancer cells.
Keppler-Hafkemeyer A; Brinkmann U; Pastan I
Biochemistry; 1998 Dec; 37(48):16934-42. PubMed ID: 9836586
[TBL] [Abstract][Full Text] [Related]
7. Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.
Nagata S; Onda M; Numata Y; Santora K; Beers R; Kreitman RJ; Pastan I
Clin Cancer Res; 2002 Jul; 8(7):2345-55. PubMed ID: 12114439
[TBL] [Abstract][Full Text] [Related]
8. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M
Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
Wolf P; Elsässer-Beile U
Int J Med Microbiol; 2009 Mar; 299(3):161-76. PubMed ID: 18948059
[TBL] [Abstract][Full Text] [Related]
10. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells.
Arora N; Klimpel KR; Singh Y; Leppla SH
J Biol Chem; 1992 Aug; 267(22):15542-8. PubMed ID: 1639793
[TBL] [Abstract][Full Text] [Related]
11. Recombinant immunotoxins containing the VH or VL domain of monoclonal antibody B3 fused to Pseudomonas exotoxin.
Brinkmann U; Lee BK; Pastan I
J Immunol; 1993 Apr; 150(7):2774-82. PubMed ID: 8454854
[TBL] [Abstract][Full Text] [Related]
12. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
Siegall CB; FitzGerald DJ; Pastan I
Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396
[No Abstract] [Full Text] [Related]
13. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I
Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032
[TBL] [Abstract][Full Text] [Related]
14. Generation of a potent chimeric toxin by replacement of domain III of Pseudomonas exotoxin with ricin A chain KDEL.
Pitcher C; Roberts L; Fawell S; Zdanovsky AG; FitzGerald DJ; Lord JM
Bioconjug Chem; 1995; 6(5):624-9. PubMed ID: 8974463
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
[TBL] [Abstract][Full Text] [Related]
16. Target-specific cytotoxic effects on HER2-expressing cells by the tripartite fusion toxin ZHER2:2891-ABD-PE38X8, including a targeting affibody molecule and a half-life extension domain.
Liu H; Seijsing J; Frejd FY; Tolmachev V; Gräslund T
Int J Oncol; 2015 Aug; 47(2):601-9. PubMed ID: 26046132
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol.
Ogata M; Fryling CM; Pastan I; FitzGerald DJ
J Biol Chem; 1992 Dec; 267(35):25396-401. PubMed ID: 1460035
[TBL] [Abstract][Full Text] [Related]
18. Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia.
Kreitman RJ; Chaudhary VK; Kozak RW; FitzGerald DJ; Waldman TA; Pastan I
Blood; 1992 Nov; 80(9):2344-52. PubMed ID: 1421405
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein.
FitzGerald DJ; Fryling CM; Zdanovsky A; Saelinger CB; Kounnas M; Winkles JA; Strickland D; Leppla S
J Cell Biol; 1995 Jun; 129(6):1533-41. PubMed ID: 7790352
[TBL] [Abstract][Full Text] [Related]
20. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
Zielinski R; Lyakhov I; Jacobs A; Chertov O; Kramer-Marek G; Francella N; Stephen A; Fisher R; Blumenthal R; Capala J
J Immunother; 2009 Oct; 32(8):817-25. PubMed ID: 19752752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
